Literature DB >> 10362664

Peroxynitrite contributes to spontaneous loss of cardiac efficiency in isolated working rat hearts.

P Ferdinandy1, D Panas, R Schulz.   

Abstract

We examined the mechanism of the time- and protein synthesis-dependent decline in cardiac mechanical function in isolated working rat hearts. Hearts were perfused with Krebs-Henseleit buffer for 120 min in the presence or absence of the protein synthesis inhibitor cycloheximide (CX; 10 microM). Cardiac work remained stable for 60 min and then spontaneously decreased during 60-120 min of perfusion. This was accompanied by an increase in myocardial inducible nitric oxide synthase (iNOS) and xanthine oxidase (XO) activities and enhanced dityrosine formation in the perfusate, an indicator of peroxynitrite generation. CX markedly attenuated the loss in contractile function and prevented the increase in iNOS and XO activities and dityrosine level. Despite the decline in cardiac work in control hearts, the coupling between tricarboxylic acid (TCA) cycle activity and oxygen consumption remained constant in both groups. ATP, creatine phosphate, and glycogen levels were not different between control and CX groups and did not differ over 120 min of perfusion. We concluded that the delayed and spontaneous loss in myocardial mechanical function in isolated working rat hearts is 1) attenuated by CX treatment, 2) accompanied by a concomitant increase in both iNOS and XO activities and peroxynitrite generation in the heart, and 3) not dependent on a direct impairment in myocardial ATP production, myocardial oxygen consumption, or TCA cycle acetyl-CoA production but may be due to an inefficiency of the heart to utilize ATP for contractile work.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10362664     DOI: 10.1152/ajpheart.1999.276.6.H1861

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  19 in total

1.  Biphasic effect of SIN-1 is reliant upon cardiomyocyte contractile state.

Authors:  Mark J Kohr; Honglan Wang; Debra G Wheeler; Murugesan Velayutham; Jay L Zweier; Mark T Ziolo
Journal:  Free Radic Biol Med       Date:  2008-04-04       Impact factor: 7.376

Review 2.  Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection.

Authors:  Hans Erik Bøtker; Derek Hausenloy; Ioanna Andreadou; Salvatore Antonucci; Kerstin Boengler; Sean M Davidson; Soni Deshwal; Yvan Devaux; Fabio Di Lisa; Moises Di Sante; Panagiotis Efentakis; Saveria Femminò; David García-Dorado; Zoltán Giricz; Borja Ibanez; Efstathios Iliodromitis; Nina Kaludercic; Petra Kleinbongard; Markus Neuhäuser; Michel Ovize; Pasquale Pagliaro; Michael Rahbek-Schmidt; Marisol Ruiz-Meana; Klaus-Dieter Schlüter; Rainer Schulz; Andreas Skyschally; Catherine Wilder; Derek M Yellon; Peter Ferdinandy; Gerd Heusch
Journal:  Basic Res Cardiol       Date:  2018-08-17       Impact factor: 17.165

Review 3.  Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.

Authors:  Pál Pacher; Alex Nivorozhkin; Csaba Szabó
Journal:  Pharmacol Rev       Date:  2006-03       Impact factor: 25.468

4.  Impact of lactate in the perfusate on function and metabolic parameters of isolated working rat heart.

Authors:  Arzu Onay-Besikci
Journal:  Mol Cell Biochem       Date:  2006-09-06       Impact factor: 3.396

5.  Nitrite confers protection against myocardial infarction: role of xanthine oxidoreductase, NADPH oxidase and K(ATP) channels.

Authors:  John E Baker; Jidong Su; Xiangping Fu; Anna Hsu; Garrett J Gross; James S Tweddell; Neil Hogg
Journal:  J Mol Cell Cardiol       Date:  2007-07-31       Impact factor: 5.000

6.  Matrix metalloproteinase inhibitors attenuate endotoxemia induced cardiac dysfunction: a potential role for MMP-9.

Authors:  Manoj M Lalu; Cindy Q Gao; Richard Schulz
Journal:  Mol Cell Biochem       Date:  2003-09       Impact factor: 3.396

7.  Targeting of phospholamban by peroxynitrite decreases beta-adrenergic stimulation in cardiomyocytes.

Authors:  Mark J Kohr; Honglan Wang; Debra G Wheeler; Murugesan Velayutham; Jay L Zweier; Mark T Ziolo
Journal:  Cardiovasc Res       Date:  2007-09-19       Impact factor: 10.787

8.  Acrolein activates matrix metalloproteinases by increasing reactive oxygen species in macrophages.

Authors:  Timothy E O'Toole; Yu-Ting Zheng; Jason Hellmann; Daniel J Conklin; Oleg Barski; Aruni Bhatnagar
Journal:  Toxicol Appl Pharmacol       Date:  2009-02-07       Impact factor: 4.219

Review 9.  Pyruvate enhancement of cardiac performance: Cellular mechanisms and clinical application.

Authors:  Robert T Mallet; Albert H Olivencia-Yurvati; Rolf Bünger
Journal:  Exp Biol Med (Maywood)       Date:  2017-11-20

Review 10.  Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.

Authors:  Cristine E Berry; Joshua M Hare
Journal:  J Physiol       Date:  2003-12-23       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.